Title of article
The efficacy and safety of interferons for the treatment of patients with COVID-19: protocol for systematic review and meta-analysis of controlled trials
Author/Authors
Noormandi, Afsaneh Department of Pharmacotherapy - Atieh Hospital, Tehran , Fathalipour, Mohammad Department of Pharmacology and Toxicology - Faculty of Pharmacy - Hormozgan University of Medical Sciences, Bandar Abbas , Daryabeygi-Khotbehsara, Reza Deakin University, Geelong, Australia , Hassanipour, Soheil Gastrointestinal and Liver Diseases Research Center - Guilan University of Medical Sciences, Rasht
Pages
3
From page
1
To page
3
Abstract
COVID-19 has since been declared a global pandemic by the World Health Organization (WHO), infecting millions worldwide. In the absence of an approved antiviral treatment, several medications are currently being evaluated for their therapeutic effectiveness in the treatment of COVID-19. The use of Interferon (INF) subtypes previously examined in the treatment of SARS and MERS is also being initiated in some clinical trials. Although different clinical trials were evaluated IFNs in the treatment of COVID-19, its safety and efficacy remain unknown. Therefore, this study aims to systematically assess IFNs efficacy and safety in treating patients with COVID-19.
Keywords
COVID-19 , Interferons , Systematic Review , Meta-Analysis
Journal title
Health Technology Assessment in Action
Serial Year
2020
Record number
2630870
Link To Document